UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025677
Receipt number R000026156
Scientific Title Anesthetic drugs effect myocardial protection for ischemia-reperfusion injury on human atrial tissue.
Date of disclosure of the study information 2017/02/01
Last modified on 2021/01/20 13:41:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Anesthetic drugs effect myocardial protection for ischemia-reperfusion injury on human atrial tissue.

Acronym

Anesthetic drugs effect myocardial protection for ischemia-reperfusion injury on human atrial tissue.

Scientific Title

Anesthetic drugs effect myocardial protection for ischemia-reperfusion injury on human atrial tissue.

Scientific Title:Acronym

Anesthetic drugs effect myocardial protection for ischemia-reperfusion injury on human atrial tissue.

Region

Japan


Condition

Condition

valve disease, coronary artery disease, aortic aneurysm, aortic dissection

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We detect the effect of the myocardiac protection on human atrial muscle on operation. We investigate the effect of the calcium paradox or the oxgen paradox on the cell of human atrial muscle with inhalation anesthetic drugs(sevoflurane, desflurane), intravenous anesthetic drugs(propofol, midazolam, dexmedetomidine), narcotic drugs(fentanyl, remifentanil, morphine).

Basic objectives2

Others

Basic objectives -Others

In addition, we investigate these anesthetic effects on TRPC(transient receptor protential canonical) in regard to the calcium paradox or the effect on L-type calcium channel in regard to the oxgen paradox.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The difference of intraceller electric current with patch clamp method.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

the case that right uppendage is resected when extracorporeal membrane oxygenation starts.

Key exclusion criteria

the expansion of right atrium.

Target sample size

54


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hirotoshi Kitagawa

Organization

Shiga University of Medical Science

Division name

anesthesiology

Zip code


Address

Tukinowa town Seta Otu city Shiga prefecture

TEL

077-548-2111

Email

mshimizu@belle.shiga-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hirotoshi Kitagawa

Organization

Shiga University of Medical Science

Division name

anesthesiology

Zip code


Address

Tukinowa town Seta Otu city Shiga prefecture

TEL

077-548-2281

Homepage URL


Email

hqanes@belle.shiga-med.ac.jp


Sponsor or person

Institute

Shiga University of Medical Science

Institute

Department

Personal name



Funding Source

Organization

Shiga University of Medical Science

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 01 Month 01 Day

Date of IRB

2017 Year 02 Month 01 Day

Anticipated trial start date

2017 Year 02 Month 01 Day

Last follow-up date

2021 Year 01 Month 20 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

no special affairs


Management information

Registered date

2017 Year 01 Month 14 Day

Last modified on

2021 Year 01 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026156


Research Plan
Registered date File name
2017/01/14 document.s.161221.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name